UCORE RARE METALS INC (UCU.CA) Fundamental Analysis & Valuation

TSX-V:UCUCA90348V3011

Current stock price

6.05 CAD
-0.57 (-8.61%)
Last:

This UCU.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. UCU.CA Profitability Analysis

1.1 Basic Checks

  • UCU had negative earnings in the past year.
  • UCU had a negative operating cash flow in the past year.
  • UCU had negative earnings in each of the past 5 years.
  • UCU had a negative operating cash flow in each of the past 5 years.
UCU.CA Yearly Net Income VS EBIT VS OCF VS FCFUCU.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

  • UCU has a worse Return On Assets (-42.61%) than 60.46% of its industry peers.
  • With a Return On Equity value of -67.99%, UCU perfoms like the industry average, outperforming 41.48% of the companies in the same industry.
Industry RankSector Rank
ROA -42.61%
ROE -67.99%
ROIC N/A
ROA(3y)-14.84%
ROA(5y)-13.5%
ROE(3y)-19.73%
ROE(5y)-16.9%
ROIC(3y)N/A
ROIC(5y)N/A
UCU.CA Yearly ROA, ROE, ROICUCU.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10 -20 -30

1.3 Margins

  • UCU does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
UCU.CA Yearly Profit, Operating, Gross MarginsUCU.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024

3

2. UCU.CA Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for UCU has been increased compared to 1 year ago.
  • Compared to 5 years ago, UCU has more shares outstanding
  • Compared to 1 year ago, UCU has a worse debt to assets ratio.
UCU.CA Yearly Shares OutstandingUCU.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
UCU.CA Yearly Total Debt VS Total AssetsUCU.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • UCU has an Altman-Z score of 12.87. This indicates that UCU is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 12.87, UCU is in the better half of the industry, outperforming 65.69% of the companies in the same industry.
  • A Debt/Equity ratio of 0.25 indicates that UCU is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.25, UCU is doing worse than 67.27% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Altman-Z 12.87
ROIC/WACCN/A
WACCN/A
UCU.CA Yearly LT Debt VS Equity VS FCFUCU.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

2.3 Liquidity

  • UCU has a Current Ratio of 1.24. This is a normal value and indicates that UCU is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of UCU (1.24) is comparable to the rest of the industry.
  • A Quick Ratio of 1.24 indicates that UCU should not have too much problems paying its short term obligations.
  • UCU has a Quick ratio (1.24) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.24
Quick Ratio 1.24
UCU.CA Yearly Current Assets VS Current LiabilitesUCU.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

1

3. UCU.CA Growth Analysis

3.1 Past

  • UCU shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -58.95%.
EPS 1Y (TTM)-58.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-482.71%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 51.54% on average over the next years. This is a very strong growth
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-81.46%
EPS Next 2Y41.42%
EPS Next 3Y51.54%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
UCU.CA Yearly Revenue VS EstimatesUCU.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2026 2027 2028 2029 50M 100M 150M 200M
UCU.CA Yearly EPS VS EstimatesUCU.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2027 0 0.2 -0.2

1

4. UCU.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for UCU. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
UCU.CA Price Earnings VS Forward Price EarningsUCU.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
UCU.CA Per share dataUCU.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4

4.3 Compensation for Growth

  • A more expensive valuation may be justified as UCU's earnings are expected to grow with 51.54% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3Y51.54%

0

5. UCU.CA Dividend Analysis

5.1 Amount

  • No dividends for UCU!.
Industry RankSector Rank
Dividend Yield 0%

UCU.CA Fundamentals: All Metrics, Ratios and Statistics

UCORE RARE METALS INC

TSX-V:UCU (3/16/2026, 7:00:00 PM)

6.05

-0.57 (-8.61%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)11-25
Earnings (Next)04-27
Inst Owners0.14%
Inst Owner ChangeN/A
Ins Owners0.27%
Ins Owner ChangeN/A
Market Cap682.02M
Revenue(TTM)N/A
Net Income(TTM)-32.39M
Analysts84
Price Target15.81 (161.32%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)26.53%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)-20%
EPS NY rev (1m)0%
EPS NY rev (3m)-28.81%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 14.31
P/tB 16.83
EV/EBITDA N/A
EPS(TTM)-0.39
EYN/A
EPS(NY)0
Fwd EYN/A
FCF(TTM)-0.08
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS0
BVpS0.42
TBVpS0.36
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -42.61%
ROE -67.99%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-14.84%
ROA(5y)-13.5%
ROE(3y)-19.73%
ROE(5y)-16.9%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 16.81%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.24
Quick Ratio 1.24
Altman-Z 12.87
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)1731.92%
Cap/Depr(5y)1254.27%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-58.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-482.71%
EPS Next Y-81.46%
EPS Next 2Y41.42%
EPS Next 3Y51.54%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y13.11%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year20.52%
EBIT Next 3Y97.15%
EBIT Next 5Y62.3%
FCF growth 1Y0.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-116.25%
OCF growth 3YN/A
OCF growth 5YN/A

UCORE RARE METALS INC / UCU.CA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of UCORE RARE METALS INC (UCU.CA) stock?

ChartMill assigns a fundamental rating of 1 / 10 to UCU.CA.


What is the valuation status for UCU stock?

ChartMill assigns a valuation rating of 1 / 10 to UCORE RARE METALS INC (UCU.CA). This can be considered as Overvalued.


Can you provide the profitability details for UCORE RARE METALS INC?

UCORE RARE METALS INC (UCU.CA) has a profitability rating of 0 / 10.


What is the financial health of UCORE RARE METALS INC (UCU.CA) stock?

The financial health rating of UCORE RARE METALS INC (UCU.CA) is 3 / 10.